Secretion of aspartic (acid) proteinase by Candida albicans is inhibited by the action of a new anticandidal agent, L-lysyl-l~-norvalyl-[NL(4-methoxyfumaroyl)]-L-Z3-diaminopropanoic acid (Lys-Nva-FMDP), at low, even sub-minimum inhibitory concentrations. The observed phenomenon is a direct consequence of inhibition of the enzyme, glucosamine-6-phosphate synthase. As a result of this inhibition, biosynthesis of candidal mannoproteins is markedly reduced. A possible correlation between general inhibition of mannoprotein biosynthesis and acid proteinase secretion is suggested. The reported inhibition of acid proteinase secretion by Lys-Nva-FMDP is more specific than the previously described effects of methyl patricim 5-fluorocytosine and fenticonazole.The secretory aspartic proteinase of Candida albicans is generally considered to be a virulence factor of this opportunistic pathogen [22,30]. Secretion of proteinase was found to be correlated with other virulence properties of C. albicans cells, such as adherence [11]. In light of recent reports, the physiological role of this enzyme during colonization of the host organism by the fungus is thought to be: (i) degradation of skin and mucosal barriers which augments the adherence of fungal cells to host tissues [4,14,16]: (ii) digestion of host proteins in order to supply nutrients [20]; and (iii) breaking the immune barrier by attacking lymphocytes and macrophages [11,22]. Therefore, antimycotics able to inhibit either acid proteinase activity or its secretion should be considered as especially valuable potential anticandidal drugs. Such a phenomenon has been observed for methyl patricin, 5-fluorocytosine and fenticonazole, but not for other antifungal azoles [3]. On the other hand, pepstatin, a selective inhibitor of aspartic proteases, given parenterally proved effective against systemic murine candidosis [33].Antifungal properties of rationally designed synthetic oligopeptides containing N-(4-methoxytumaroyl)-L-2,3-dlamlnopropanolc acid (FMDP) residue have recently been described [1,2]. These compounds were shown to be chemotherapeutically effective anti-candidal agents in the model of generalized candidosis in mice [25]. Studies on the mechanism of action of FMDP-peptides revealed that they were transported into C. albicans cells by peptide permeases and cleaved by intracellular peptidases; the released FMDP selectively inactivated the enzyme, glucosamine-6-phosphate (GlcN-6-P) synthase [23]. The shortage of the biosynthetic glucosamine resulted in inhibition of biosynthesis of glucosamine-containing cell wall macromolecules: chitin and mannoprotein [23]. Previously, we showed that inhibition of GlcN-6-P synthase resulted in decreased secretion of two glycoprotein secretory enzymes: invertase and